VHT
HealthcareVanguard Health Care Index Fund ETF Shares
Vanguard · Tracks MSCI US Investable Market Health Care 25/50 Index · Inception Feb 5, 2004
Composite score
Based on a 0.090% expense ratio.
Based on $20.39B in net assets.
Top-10 holdings represent 50.3% of net assets.
Healthcare base · ETF wrapper · 1.58% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.1).
Use VHT in our tools
Tool · Cost
Compare VHT's fee against another fund
Compounds the 0.090% expense ratio against a peer over decades.
Tool · Overlap
Compare VHT's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Healthcare funds.
Tool · TLH
Find a tax-loss harvesting partner for VHT
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Where should this fund live across your accounts?
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Eli Lilly & Co | 12.54% |
| 2 | Johnson & Johnson | 8.74% |
| 3 | AbbVie Inc | 6.08% |
| 4 | Merck & Co Inc | 4.58% |
| 5 | UnitedHealth Group Inc | 3.94% |
| 6 | Amgen Inc | 3.10% |
| 7 | Abbott Laboratories | 3.00% |
| 8 | Thermo Fisher Scientific Inc | 2.92% |
| 9 | Gilead Sciences Inc | 2.74% |
| 10 | Intuitive Surgical Inc | 2.68% |
Compare VHT with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open VHT at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.